Giannoni Maria Fabrizia, Palombo Giovanni, Sbarigia Enrico, Speziale Francesco, Zaccaria Alvaro, Fiorani Paolo
Department of Vascular Surgery, University of Rome La Sapienza, Rome, Italy.
J Endovasc Ther. 2003 Apr;10(2):208-17. doi: 10.1177/152660280301000208.
To compare unenhanced and enhanced ultrasound imaging to computed tomographic angiography (CTA) or magnetic resonance angiography (MRA) for surveillance of aortic endografts.
Thirty consecutive patients (29 men; mean age 69 years, range 50-82) who underwent endovascular aortic aneurysm repair agreed to participate in a follow-up program. Patients underwent CTA (26/30) or MRA (4/30), plain abdominal radiography, and unenhanced and enhanced ultrasound examinations at 3, 12, and 24 months to evaluate aneurysm diameter, endoleaks, and graft patency. The accuracy of ultrasound was compared with CTA or MRA as the reference standards.
Twenty-six patients reached the 24-month assessment (mean follow-up 30 months, range 6-60). All endoleaks detected by CTA or MRA were confirmed by enhanced ultrasound; the aneurysm diameter in these patients remained unchanged or increased. In patients without endoleaks on any imaging method, the sac diameter remained unchanged or decreased. Endoleaks disclosed by enhanced ultrasound alone, all type II, numbered 16 at 3 months, 6 at 12 months, and 3 at 24 months. In this group, the aneurysm diameter remained unchanged or increased. Enhanced ultrasound yielded 100% sensitivity in detecting endoleaks, but compared with CTA and MRA, all endoleaks detected by enhanced ultrasound alone were false positives (mean specificity 65%). Nevertheless, because changes in the postoperative aneurysm diameter were similar in patients with endoleaks detectable on CTA/MRA and on enhanced ultrasound ("true positives") and in those with endoleaks detectable only on enhanced ultrasound ("false positives"), some endoleaks were possibly "true positive" results.
Enhanced ultrasound is a useful method in the long-term surveillance of endovascular aortic aneurysm repairs, possibly in association with CTA or MRA. Enhanced ultrasound also seems able to identify endoleaks missed by other imaging techniques, but this conclusion awaits further investigation.
比较未增强和增强超声成像与计算机断层血管造影(CTA)或磁共振血管造影(MRA)在主动脉内移植物监测中的应用。
连续30例接受血管内腹主动脉瘤修复术的患者(29例男性;平均年龄69岁,范围50 - 82岁)同意参与一项随访计划。患者在3个月、12个月和24个月时接受CTA(26/30)或MRA(4/30)、腹部平片以及未增强和增强超声检查,以评估动脉瘤直径、内漏和移植物通畅情况。将超声的准确性与CTA或MRA作为参考标准进行比较。
26例患者完成了24个月的评估(平均随访30个月,范围6 - 60个月)。CTA或MRA检测到的所有内漏均经增强超声证实;这些患者的动脉瘤直径保持不变或增大。在任何成像方法均未发现内漏的患者中,瘤腔直径保持不变或减小。仅由增强超声发现的内漏均为II型,3个月时为16例,12个月时为6例,24个月时为3例。在该组中,动脉瘤直径保持不变或增大。增强超声检测内漏的敏感性为100%,但与CTA和MRA相比,仅由增强超声检测到的所有内漏均为假阳性(平均特异性65%)。然而,由于在CTA/MRA和增强超声上可检测到内漏的患者(“真阳性”)以及仅在增强超声上可检测到内漏的患者(“假阳性”)术后动脉瘤直径的变化相似,一些内漏可能是“真阳性”结果。
增强超声是血管内腹主动脉瘤修复术长期监测的一种有用方法,可能与CTA或MRA联合使用。增强超声似乎也能够识别其他成像技术遗漏的内漏,但这一结论有待进一步研究。